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Objective: To explore the diagnosis of rectal carcinoid tumors and to adopt the best method of treatment.
Patients and methods: A group of 312 cases of pathologically conﬁrmed rectal carcinoid were analyzed
retrospectively. Data were obtained retrospectively from a database of all colorectal malignancies at Qilu
Hospital from January 2004 to December 2012. 4072 colorectal malignant tumors and 312 rectal carci-
noid tumors were diagnosed. Endoscopic resection was performed on 44 patients, while the other 248
underwent anus partial extended radical polypectomy. We evaluated the clinical manifestations, diag-
nosis, treatment and follow-ups regarding carcinoids and the relation between tumor diameter and the
rate of recurrence or metastasis after surgery.
Results: There is no recurrence or metastasis after the transanal local resection in 284 cases with the
tumor diameter less than 2 cm, 6 months to 7 years’ follow-up. While, in 12 cases with the tumor
diameter more than 2 cm radical surgery was performed, 8 cases had liver metastases at the time of the
diagnosis of rectal carcinoid, 4 cases had no recurrence or metastasis after two and a half years’ of follow
ups, there is no recurrence or metastasis in 4 cases of multiple rectal carcinoids, whom all underwent
radical surgery, follow ups continued for 2 years.
Conclusion: Early diagnosis and treatment is important for rectal carcinoids, local resection is a simple,
safe and effective treatment for carcinoids with a tumor diameter less than 2 cm.
 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.What is already known on this topic?
Rectal carcinoid tumors originate from APUD.
What this study adds?
Early diagnosis and treatment is important for rectal
carcinoids.
1. Introduction
Rectal carcinoid tumors originate from APUD (amine precursor
uptake and decarboxylation) cells in the rectal mucosa. Althoughby Elsevier Ltd. All rights reservedrectal carcinoid tumors are rare, they have their own unique clinical
manifestations. Rectal carcinoid tumors are usually found inci-
dentally during endoscopic examination. The typical endoscopic
examination of rectal carcinoid tumors reveals smooth, round,
sessile elevations covered with normal-appearing or yellow-
discolored mucosa. This article analyses 312 cases of pathologi-
cally conﬁrmed rectal carcinoids taken from clinical data obtained
from Qilu Hospital and other hospitals in Jinan, Shandong Province,
during January 2004 to December 2012 retrospectively and dis-
cusses the clinical manifestations, diagnosis, treatment and follow-
ups regarding carcinoids.2. clinical data
2.1. General information
A group of 312 cases, including 180 males and 132 females, aged
23e74 years old, with a median age of 48.02 years during January.
Table 1
Clinical manifestations of Rectal Carcinoid patients.
None Bowel habits change Lower abdominal pain Intermittent bleeding stool Anal discomfort Tenesmus
Diarrhea Constipation
Number 124 88 44 76 48 36 24
Rate (%) 39.74 28.21 14.10 24.36 15.38 11.54 7.69
Table 2
Relation between tumor diameter and the rate of recurrence or metastasis after
surgery.
D (cm) Number of patients
with recurrence or
metastasis after
surgery
Number of patients
without recurrence
or metastasis after
surgery
Total Rate of
recurrence
or metastasis
after surgery
(%)
D < 0.5 0 44 44 0
0.5 < D < 2.0 0 248 248 0
D > 2.0 4 12 16 25
Total 4 304 308 1.3
P ¼ 0.000 (Fisher’s exact).
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Surgery in Qilu Hospital were included in this study.
All lesions were diagnosed histopathologically as rectal carci-
noids by the Department of Pathology in Qilu hospital. These
accounted for 7.66 percent of colorectal cancers treated in the same
period (312/4072) (Table 1).
2.2. Clinical manifestations
2.2.1. Clinical ﬁndings
2.2.2. Rectal touch examination
In 276 of 312 cases (88.46%) rectal carcinoids were located less
than 8 cm from the anus. Tumors, which are single, smooth, hard,
clear edged, and without blood, were touchable in submucosa with
a digital rectal examination. The others (11.54%) more than 10 cm
from the anus were not palpable with a digital rectal examination.
In this group, the tumor size is from 2 mm to 40 mm, occupying 50
percent of the intestinal wall. In 196 cases the size of tumors is less
than 1 cm and 1e2 cm in 96 cases, and larger than 2 cm in 20 cases.
2.3. Endoscopic ﬁndings
268 cases of rectal carcinoid tumors presented with a single
circular sub mucosal mass protruding into the intestinal lumen,
having wide base, ﬂat or steep edges or a bulge, yellow or pale in
color. Tumors with less than 2 cm diameter were covered by
normal mucosa on the surface, and their texture was hard. Ulcers
were visible on the surface of tumors with diameter larger than
2 cm. 44 cases of rectal carcinoid presented with obvious lumps.
3. Results
44 cases of rectal carcinoid tumors (D 0.5 cm)with endoscopic
resection had no recurrence or metastasis, subsequent 6 months e
5 years’ postoperative follow-up. There is also no recurrence or
metastasis in 248 cases (D ¼ 0.5 cm w 2 cm) treated with anus
partial extended radical polypectomy, followed up for 1e5 years.
Among 20 cases (D > 2 cm), 8 cases had intrahepatic metastasis
before the disease was diagnosed, 4 patients without bleeding or
obstructive symptoms did not undergo surgery, and 4 cases, treated
with colorectal cancer radical resection because of obstructive
symptoms, died of liver extensive metastasis in the following 2
years. Another 12 cases, having undergone colorectal cancer radical
resection, showed no recurrence or metastasis during a 4 to 6 and a
half year postoperative follow-up (Table 2).
We found P < 0.05, according to the outcome of Fisher’s exact
probabilities. So we can conclude that the relation between tumor
diameter and the rate of recurrence or metastasis after surgery is
statistically signiﬁcant. When the diameter is bigger than 2.0 cm,
the rate will be higher.
4. Discussion
The term carcinoid is derived from the German word “karzi-
noide,” ﬁrst used by Oberndorfer in 1907 to describe tumors thatare more indolent than typical adenocarcinomas. Carcinoid tumors
in a wide range of organs have subsequently been identiﬁed, most
commonly involving the lungs, bronchi, and gastrointestinal tracts.
Carcinoid grows slowly but has the possibility of local invasive
growth and late metastasis, it is able to transfer by lymphatics and
blood. In 1914 Gossett revealed the tumor cell nuclei have argyr-
ophil staining character, and pointed out that the Kulchizky carci-
noid are from intestinal epithelial cells. Carcinoids located in the
hindgut of rectum are mostly non-argyrophilic, do not produce
biologically active amines, and don’t have carcinoid syndrome
manifestations [1,2] .The incidence of carcinoid tumors inside the
small intestine is by far the highest, accounting for 30.8%, followed
by the rectum, colon, pancreas, stomach and appendix, which ac-
counts for 26.3%, 17.6%, 12.1%, 8.9% and 5.7% [3e5]. The incidence of
carcinoid tumors has increased yearly, by now, all the malignant
tumors of the gastrointestinal tract and carcinoid tumors have
become second to the common colon cancer tumors [5,6].
4.1. Diagnosis
Rectal carcinoids have no obvious clinical speciﬁcity, and more
than 1/3 patients have no symptoms. Other patients have varying
degrees of change in bowel habits, for example, abdominal
discomfort, intermittent bloody stool, anal discomfort.
It may be associated with concomitant intestinal polyps, colitis,
hemorrhoids and so on, as the manifestations are not unique. But
rectal carcinoid has its particular clinical pathology. For instance,
the tumor is generally located on the front or side wall of the
rectum and 3e8 cm from the anal margin [7]. Therefore, careful and
meticulous rectal examination is helpful to ﬁnd over 90% of cases of
rectal carcinoid tumors. If we ﬁnd round, smooth the sub mucosal
induration on the rectal wall, we should consider about this dis-
ease. Because the tumor is located under the mucosa with clear
boundary and smooth surface, the general pathological examina-
tion of the surface tissue is chronic inﬂammation [7], its positive
biopsy rate depends on the technology. It can be generally
conﬁrmed by cutting tissue from deep nodule center or frequency
electrosurgical excision. Benign and malignant rectal carcinoid is
judged by 4 factors, such as tumor size myometrial invasion, single
or multiple, and with or without clinical symptoms. For the tumor
(D < lcm), Malignant transformation rate is 4%, the transfer rate is
3%, and it has very few myometrial invasion; for tumor (D ¼ 1e
2 cm), malignant transformation rate is 10%, the transfer rate is 11%,
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82%, and metastasis is 74%, easy myometrial invasion. Myometrial
invasion, multiple carcinoids, blood in the stool, and tenesmus
performance are important indicators of malignancy. Rectal carci-
noids of 10.1e20 mm in diameter have a metastasis risk of 17e42
(81) % for neuroendocrine rectal neoplasms > 20 mm in size this
risk increases to 60e80% [8]. Vascular invasion was also a prog-
nostic indicator [9]. Rectal carcinoid patients had higher morbidity
for colorectal, small intestine, stomach and oesophageal cancer or
secondary lung, prostate and urinary tract tumors [6,10]. It is
important that digital rectal examinations play essential roles in the
diagnosis of rectal carcinoids. Patients with rectal carcinoid should
pay attention to tumors at other parts or metastases.
4.2. Treatment
The best treatment of patients with rectal carcinoid tumors re-
mains uncertain. By now, surgical resection is most effective way to
treat rectal carcinoids. The prognosis of surgical resection is better
for patients who haven’t lymphatic and hematogenous metastasis
in early stage. Chemotherapy and radiation therapy are difﬁcult to
achieve the purpose of recovery, and only used for palliative
treatment of advanced patients. Surgery is divided into two cate-
gories, local excision and radical surgery.
Local excision is sufﬁcient for a tumor (D< 1 cm)which does not
infringe the muscle layer and has no metastasis, local radical tu-
mors can call for radical treatment, but resection must reach the
deep muscle layers; for tumors with a diameter between 1 and
2 cm, with or without myometrial invasion, metastasis rate that is
less than 10% and viable anal or sacral resection partial expansion.
Radical Surgery is necessary if there are cancer tissues at the
cutting edge, it is insufﬁcient to do an extended resection, and if
necessary an abdominal expanded local excision should be per-
formed; for tumors (D> 2 cm), the rate of lymph nodemetastasis is
signiﬁcantly increased, and most of them need abdominal colo-
rectal cancer radical resection. The resection is done by the role of
gastrointestinal tumors resection, and in accordance with lymph
node dissection, such as anterior resection, abdominal-perineal
resection, post-pelvic dissection and modiﬁed Bacon surgery
[10.11].
We learnt that for tumors with a size of less than 5 mm in
diameter, colonoscopy EMR treatment is safe and reliable, and 44
cases of resected specimen showed no myometrial and invasion
recurrence or metastasis during follow-ups. We recommend
expanding transanal local excision to remove the tumor and sur-
rounding normal tissue 1 cm for tumor whose diameter is between
0.5 cm and 2.0 cm and located near the anus (less than 10 cm). In
addition, an immediate postoperative histological examination is
essential, in order to make sure residual tumors do not exist at the
base or cutting edge and that there is no presence of myometrial
invasion or tumor invasion. Due to the development of endoscopic
operation technology, we have an increase in the positive removal
of larger tumors by colonoscopy.
Endoscopic removal proves challenging due to the carcinoid
being located on the sub mucosal level. Endoscopic sub mucosal
dissection is applied as a new method or conventional EMR shows
promise or potentially as a useful it is also a predominately safe
procedure to dissect or resect rectal carcinoid tumors of 10 mm,
more or less, in diameter [12].
Despite repeated technical improvements, residual tumors
which lead to relapse and metastasis are still existence .In terms of
rectal mucosa, it can still easily be sutured without tension after
removal of parts of 4e6 cm size, and there is no sign of post-
operative rectal ulcers. For tumors located more than 10 cm from
the anus, transanal operation is a difﬁcult procedure. We may needto consider endoscopic resection. Recently, it has been reported
that PPH treatment is applied for sessile colorectal polyps and for
small tumors in China [14].
We believe that the tumor location is out of sight when PPH
stapler tightening is present, and this makes the extent of surgical
resection uncontrolled and inaccurate, in spite of this, it proves less
time consuming and less bleeding occurs. For tumor’s (D > 2 cm),
multiple carcinoids and tumor’s that relapse once, we recommend
radical surgery. Of course, the particular patient should be
individualized.4.3. postoperative follow-up
Prognosis of rectal carcinoid is affected by many factors, such as
gender, tumor size, depth of invasion, growth area, metastasis,
whether it be the application of drug therapy and so it is an
important prognostic factor, so the rectal carcinoid patients should
be followed up consistently.
Regular checks by B ultrasound or CT Should be done due to
the fact that the main transfer organ is the liver. Incidence of
rectal carcinoid increases signiﬁcantly, due to the colonoscopy
check carried out generally in recent years. Rectal carcinoid
prognosis is usually good, and the overall 5-year survival rate is
88.4%. The majority of patients with early stage can be cured
after local excision [13]. There is no metastasis or recurrence in
284 cases (D < 2 cm) by follow-up. Early detection, early diag-
nosis and early treatment are the keys to improve survival and
prognosis.Ethical approval
None.Funding
None.Author contribution
Hong Yangong: Main Study design, Clinical data analysis,
Diagnosis.
Chengyao Shi: Data collection, Analysis, treatment, comparison
of data.
Muhammad Shahbaz: writing research paper, data analysis,
clinical data collection.
Niu Zhengchuan: Data collection, Analysis, treatment, compar-
ison of data.
Jiayong Wang: writing research paper, data analysis, clinical
data collection.
Benjia Liang: Data collection and analysis, diagnosis, and
treatment.
Fang Ruliang: Data collection, Analysis, treatment, comparison
of data.
Huijie Gao: Data collection, Analysis, treatment, comparison of
data.
Qiu Bo: writing research paper, data analysis, clinical data
collection.
Jun Niu: Main Study design, Clinical data analysis, Diagnosis,
writing research paper, data analysis, clinical data collection.Conﬂict of interest
None.
H. Yangong et al. / International Journal of Surgery 12 (2014) 408e411 411
ORIGINAL RESEARCHReferences
[1] M.A. Lewis, J.C. Yao, Molecular pathology and genetics of gastrointestinal
neuroendocrine tumours, Current Opinion in Endocrinology, Diabetes, and
Obesity 21 (1) (2014 Feb) 22e27.
[2] Varas Lorennzo, et al., Gastrointestinal carcinoid tumors, Revista Española de
Enfermedades Digestivas 102 (9) (2010) 533e537.
[3] J.C. Yaov, et al., One hundred years after “carcinoid”: epidemiology of and
prognostic factors for neuroendocrine tumors in 35825 cases in the United
States, Journal of Clinical Oncology 26 (18) (2008) 3063e3072.
[4] Lawrence, et al., The epidemiology of gastroenteropancreatic neuroendocrine
tumors, Endocrinology and Metabolism Clinics of North America 40 (2011a)
1e18 (vii).
[5] I.M. Modlin, K.D. Lye, M. Kidd, A 5-decade analysis of 13,715 carcinoid tumors,
Cancer 97 (2003) 934e959.
[6] S. Schimmack, B. Svejda, B. Lawrence, M. Kidd, I.M. Modlin, The diversity and
commonalities of gastroenteropancreatic neuroendocrine tumors, Langen-
beck’s Archives of Surgery 396 (2011) 273e298.
[7] J. Liu, Z.Q. Wang, Z.Q. Zhang, et al., Evaluation of colonoscopy in the diagnosis
and treatment of rectal carcinoid tumors with diameter less than 1 cm in 21
patients, Oncology Letters 5 (5) (2013) 1667e1671.[8] H. Scherübl, G. Klöppel, Rectal carcinoids on the rise-update, Zeitschrift fur
Gastroenterologie 47 (4) (2009) 365e371.
[9] A. Kasuga, A. Chino, N. Uragami, et al., Treatment strategy for rectal carcinoids:
a clinicopathological analysis of 229 cases at a single cancer institution,
Journal of Gastroenterology and Hepatology 27 (12) (2012) 1801e1807.
[10] I.M. Modlin, S.F. Moss, K. Oberg, et al., Gastrointestinal neuroendocrine
(carcinoid) tumours: current diagnosis and management, Medical Journal of
Australia 193 (1) (2010) 46e52.
[11] S.N. Pinchot, K. Holen, R.S. Sippel, et al., Carcinoid tumors, The Oncologist 13
(12) (2008) 1255e1269.
[12] I.H. Baek, Endoscopic submucosal dissection or conventional endoscopic
mucosal resection is an effective and safe treatment for rectal carcinoid tu-
mors: a retrospective study, Journal of Laparoendoscopic & Advanced Surgical
Techniques 20 (4) (2010) 329e331.
[13] M.S. Kim, H. Hur, B.S. Min, et al., Clinical outcomes for rectal carcinoid tumors
according to a new (AJCC 7th edition) TNM staging system: a single institu-
tional analysis of 122 patients, Journal of Surgical Oncology 107 (8) (2013 Jun)
835e841.
[14] X.D. Yang, Gong Wenjing, Ann Hui, PPH treatment of rectal sessile polyp
(Report of 4 cases), Colorectal & Anal Surgery 13 (6) (2007) 387e388.
